Sabah Kadri

  • 1430 Citations
20092020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

PhD, Carnegie Mellon University

… → 2012

Fingerprint Dive into the research topics where Sabah Kadri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 1430 Citations
  • 40 Article
  • 1 Comment/debate

A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia

Cahill, K. E., Karimi, Y. H., Karrison, T. G., Jain, N., Green, M., Weiner, H., Fulton, N., Kadri, S., Godley, L. A., Artz, A. S., Liu, H., Thirman, M. J., Le Beau, M. M., McNerney, M. E., Segal, J., Larson, R. A., Stock, W. & Odenike, O., Feb 25 2020, In : Blood Advances. 4, 4, p. 599-606 8 p.

Research output: Contribution to journalArticle

Open Access
  • 1 Scopus citations

    Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas

    Cracolici, V., Ritterhouse, L. L., Segal, J. P., Puranik, R., Wanjari, P., Kadri, S., Parilla, M. & Cipriani, N. A., Jan 1 2020, (Accepted/In press) In : American Journal of Surgical Pathology.

    Research output: Contribution to journalArticle

  • Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas

    Setia, N., Wanjari, P., Yassan, L., Niu, N., Kadri, S., Ritterhouse, L., Misdraji, J., Brown, I., Segal, J. & Hart, J., Mar 2020, In : Human pathology. 97, p. 103-111 9 p.

    Research output: Contribution to journalArticle

  • Autophagy inhibition to augment mTOR inhibition: A phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma

    Haas, N. B., Appleman, L. J., Stein, M., Redlinger, M., Wilks, M., Xu, X., Onorati, A., Kalavacharla, A., Kim, T., Zhen, C. J., Kadri, S., Segal, J. P., Gimotty, P. A., Davis, L. E. & Amaravadi, R. K., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2080-2087 8 p.

    Research output: Contribution to journalArticle

  • 21 Scopus citations

    Cerdulatinib pharmacodynamics and relationships to tumor response following oral dosing in patients with relapsed/refractory b-cell malignancies

    Coffey, G. P., Feng, J., Betz, A., Pandey, A., Birrell, M., Leeds, J. M., Der, K., Kadri, S., Lu, P., Segal, J., Wang, Y. L., Michelson, G., Curnutte, J. T. & Conley, P. B., Feb 15 2019, In : Clinical Cancer Research. 25, 4, p. 1174-1184 11 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations